Antifungal drug, TOLSURA™, now available in the US
by Press Release from Outbreak News Today on (#4885A)
Australian company, Mayne Pharma announced this week that their antifungal drug, TOLSURAa (SUBA(R)-itraconazole) 65mg capsule, will be launched in the United States. TOLSURA is a new formulation of itraconazole indicated for the treatment of systemic fungal infections including blastomycosis (pulmonary and extrapulmonary), histoplasmosis (including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis) and aspergillosis (pulmonary and extrapulmonary, ["]
The post Antifungal drug, TOLSURAa, now available in the US appeared first on Outbreak News Today.